Pharmacists in Easton, Pennsylvania


78 Pharmacists found in Easton
female pharmacist

Samantha Price, PHARM. D


Pharmacist
3519 Nazareth Rd, Easton, PA 18045
610-258-3961    

female pharmacist

Samantha Rosenberg, CPHT


Pharmacist
3825 Sullivan Trl, Easton, PA 18040
610-252-6756    

male pharmacist

Scott Edward Freemont


Pharmacist
4950 Freemansburg Ave, Easton, PA 18045
610-694-8871    



male pharmacist

Dr. Scott Borkenhagen


Pharmacist
3722 Nazareth Rd, Easton, PA 18045
610-250-8610    

female pharmacist

Sharon Horvath, RPH, PHARM D


Pharmacist
901 Northampton St, Easton, PA 18042
610-868-6116    

male pharmacist

Shawn Thomas Lynn


Pharmacist
215 Town Center Blvd, Easton, PA 18040
610-250-3651    

female pharmacist

Ms. Shelly C Blake, RPH.


Pharmacist
1955 Sullivan Trl, Easton, PA 18040
610-258-7439    

female pharmacist

Mrs. Susan Carol Baynard


Pharmacist
2024 Lehigh St, Easton, PA 18042
484-600-6666    

female pharmacist

Susan Hood, RPH


Pharmacist
3791 Easton Nazareth Hwy, Easton, PA 18045
610-515-2445     610-515-2498

female pharmacist

Mrs. Teresa A Greco, RPH


Pharmacist
250 S 21st St, Easton, PA 18042
610-250-4775    

male pharmacist

Mr. Thomas William Ireland, R.PH.


Pharmacist
304 Village At Stones Crossing Rd, Easton, PA 18045
610-829-2478    

female pharmacist

Prof. Traci Litwin


Pharmacist
320 S 25th St, Easton, PA 18042
610-258-2324    

female pharmacist

Trisha Ann Espinosa


Pharmacist
3722 Easton Nazareth Hwy, Easton, PA 18045
610-250-8610    

male pharmacist

Uri Anderson


Pharmacist
320 S 25th St, Easton, PA 18042
610-258-2324    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.